comparemela.com

Latest Breaking News On - Melt pharmaceuticals - Page 6 : comparemela.com

Harrow Health (NASDAQ:HROW) Issues Quarterly Earnings Results, Misses Estimates By $0 01 EPS

Harrow Health (NASDAQ:HROW – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.01), Briefing.com reports. Harrow Health had a negative return on equity of 1.57% and a negative net margin of 19.76%. The firm had revenue […]

Harrow Health (NASDAQ:HROW) Releases Earnings Results, Misses Estimates By $0 01 EPS

Harrow Health (NASDAQ:HROW) Releases Earnings Results, Misses Estimates By $0 01 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Q2 2023 Earnings Estimate for Harrow Health, Inc Issued By B Riley (NASDAQ:HROW)

Harrow Health, Inc. (NASDAQ:HROW – Free Report) – Investment analysts at B. Riley lifted their Q2 2023 earnings estimates for shares of Harrow Health in a note issued to investors on Thursday, July 20th. B. Riley analyst M. Mamtani now forecasts that the company will earn $0.00 per share for the quarter, up from their […]

Harrow Health, Inc (NASDAQ:HROW) Short Interest Update

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) was the recipient of a significant growth in short interest in June. As of June 30th, there was short interest totalling 3,850,000 shares, a growth of 33.2% from the June 15th total of 2,890,000 shares. Based on an average daily trading volume, of 521,100 shares, the days-to-cover […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.